Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Quest Diagnostics Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$259.690.0%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed October 23, 2026
Quest Diagnostics performs medical tests on blood and other samples for doctors, hospitals, health plans and patients.
Company outlook: revenue of $12.1B to $12.1B for Fiscal year 2026 — up 9.5% on a year earlier